Santhera Pharmaceuticals Holding AG (SANN)
SIX
Closed
Oct 15, 2026
Day's Range
14.0052 wk Range
9.57Overview - SANN - Santhera Pharmaceuticals Holding AG
Key Statistics
Valuation
Enterprise Value
216.48M
P/E (Trailing)
‪2.52‬
P/E (Forward)
‪68.72‬
PEG Ratio
‪68.72‬
Price / Sales (TTM)
‪2.28‬
EV / EBITDA
‪-59.52‬
Profitability
Gross Margin
‪86.33%‬
Profit Margin
‪-31.45%‬
Operating Margin
‪-13.58%‬
Return on Assets
‪-3.92%‬
Return on Equity
‪416.68%‬
Ownership
Shares Outstanding
13.39M
Float
12.08M
Held by Insiders
‪11.15%‬
Held by Institutions
‪14.20%‬
Price stats
50-Day Avg
‪15.55‬
200-Day Avg
‪15.40‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
2 analysts
Average price target
‪CHF 27.50‬Market Cap - SANN - Santhera Pharmaceuticals Holding AG
Peers - SANN - Santhera Pharmaceuticals Holding AG
Peer Comparison
Compared with companies in Biotechnology listed on SIX.
- SANNSIXSanthera Pharmaceuticals Holding AG231.62MMarket Cap+30.56%52-week change2.53P/E (Trailing)‪-31.45%‬Profit Margin
- BIONSIXBB Biotech AG3.08BMarket Cap+42.23%52-week change2.29P/E (Trailing)‪127.31%‬Profit Margin
- BSLNSIXBasilea Pharmaceutica Ltd814.14MMarket Cap+26.03%52-week change16.33P/E (Trailing)‪21.17%‬Profit Margin
- BIOVSIXBioVersys AG148.70MMarket Cap-7.87%52-week change-6.79P/E (Trailing)‪-386.62%‬Profit Margin
- ADXNSIXAddex Therapeutics Ltd4.92MMarket Cap-152.14%52-week change-0.39P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - SANN - Santhera Pharmaceuticals Holding AG
About
Santhera Pharmaceuticals Holding AG is a Swiss specialty pharmaceutical company headquartered in Pratteln, Switzerland, dedicated to the research, development, and commercialization of innovative medicines for patients with rare and debilitating diseases. The company primarily targets unmet medical needs in…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
